BioWorld MedTech

Sep. 6, 2016

After selling med-tech arm, Toshiba plans next-gen radiation therapy

TOKYO – Toshiba Corp. is developing a treatment for cancer that uses particle beams and will send the technology to trial next year, aiming to have a device on the market by the early 2020s. Read More

Senators make a push for incorporation of unique device identifiers into insurance claims forms

FDA hits Tosoh with third warning for U.S. operations since 2005

Ultrasound mobility device for the blind generating good vibrations in Canada

Other news to note

Appointments and advancements

Daily M&A

Financings

MDD's Cardiology Extra

Today's news in brief

BioWorld

BioWorld briefs for June 17, 2026.

News in brief

BioWorld Asia

BioWorld Asia briefs for June 16, 2026

For clonal hematopoiesis, epigenetics can be in driver’s seat

BioWorld Science

Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...

Illustration of amyloid plaques in Alzheimer's disease

Elixiron’s enrupatinib shows upbeat interim phase II AD results

BioWorld

Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...

Gene replacement rescues autism-related phenotypes in mice

BioWorld Science

Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...